I am still very on the fence on this since the Adcom. I hope we all make money when the decision arrives
MarkyBoy212
w zeszłym tygodniu
A new buy rating and 2 maintained buys very nice
A new buy rating and 2 maintained buys very nice, hoping this gets approval after earnings and award
ByronKS
w zeszłym tygodniu
Capricor earnings report
See the Capricor Therapeutics earnings report below. Good luck! 🤞🏼🍀
https://web.quartr.com/link/companies/5913/events/732825/report?rp=0&documentId=4012432
MarkyBoy212
2 tygodnie temu
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
TerraNova23
2 tygodnie temu
Anyone else think this will fail?
According to Adam Feuerstein, Capricor faces two major risks:
Weak Clinical Evidence: The FDA may consider Deramiocel's efficacy data insufficient for approval.
Public Pressure on the FDA: Capricor's public statements could suggest concerns about its chances of approval.
And there is still the 3-9 vote from before.
Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
Prayers
3 miesiące temu
This too (and yh I DO wish I did this in CFD lol)
GGGGM
3 miesiące temu
Thank God for this stock today
$CAPR to the rescue, thank you thus far... NFA
kosen
3 miesiące temu
This pattern looks exactly like yesterday.
If it completely duplicates yesterday’s pattern, we see 11.5 Today???
kosen
3 miesiące temu
What do we think
At a loss now, watching a bit
GGGGM
3 miesiące temu
We going up.. The News is here.. NFA.
$CAPR would soar today as the long awaited news is finally here.
The FDA accepted a major amendment to Capricor's Biologics License Application (BLA) containing 24-month Phase 3 HOPE-3 extension data. Instead of issuing an immediate rejection, the FDA extended the PDUFA target action date to November 22, 2026.
I got in early at $8 and waiting to see above 11 and above..
Note that THIS IS NOT A FINANCIAL ADVICE... NFA
SKM2086
3 miesiące temu
PT - $54
I'm going with a conservative $25-30. We're on the right track now. Definitely close to making permanent moves upwards.
https://uk.investing.com/news/stock-market-news/oppenheimer-upgrades-capricor-stock-rating-on-regulatory-update-93CH-4846076
MarkyBoy212
3 miesiące temu
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA nice news guys
Hazlaw1234
3 miesiące temu
$CAPR feels like one to watch very closely today 👀
The official PDUFA target date is tomorrow, Saturday 22 August, but with that falling on a weekend there’s a very real possibility we hear something from the FDA today instead.
As of now there’s been no decision announced, so I’d expect a lot of eyes on CAPR once the US session gets going and especially into after hours.
Could be a very important day for the stock. Definitely worth keeping notifications on.
NFA
Ta strona może zawierać treści generowane przez społeczność, za które Trading 212 nie ponosi odpowiedzialności. Zawsze sprawdzaj informacje samodzielnie. Trading 212 świadczy usługi wyłącznie w zakresie realizacji zleceń i nie oferuje doradztwa inwestycyjnego ani zarządzania portfelem.
Budowanie bogactwa to nawyk. Zautomatyzuj to za pomocą Pie.
Inwestuj w gotowe Pies lub twórz własne, wybierając spośród tysięcy akcji i funduszy ETF.
Dowiedz się więcej
Dowiedz się więcej
Obejrzyj film
Wejdź w posiadanie nawet najdroższych akcji takich firm jak Google, Amazon i Apple
Obejrzyj film
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lizbona
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lizbona
Zobacz wszystkie instrumenty
Wsparcie 24/7
Średni czas reakcji: 29 sekund
Zacznij bogacić się już teraz
Dołącz do ponad 5 milionów użytkowników
Pobierz aplikację
Otwórz konto
Pobierz aplikację mobilną
Wszystkie przedstawione statystyki są globalne. Liczba klientów reprezentuje zasilone konta.
Doskonała
Ocena 4,6 / 5 na podstawie 108 764 recenzji na
Trustpilot
Ocena 4,6 / 5 na podstawie 108 764 recenzji na
Trustpilot
Zaproszony
Great app very easy to use and lots of…
Great app very easy to use and lots of information. Always upto date with balances and share prices etc.
Zaproszony
Smooth experience
The whole thing is smooth and seamless and makes things easy overall.
Zaproszony
Really easy to use
Really easy to use. Secure and has the best functionality and features.
Zaproszony
Easy to keep up with as informed…
Easy to keep up with as informed everyday or week on interest made . Easy to set up account . No problems .
Zaproszony
Easy to operate and work with
Easy to operate and work with. Works very fast and accurately.
Zaproszony
How you rate the app
This app is so easy to use and safe really love it.
Zaproszony
I opened a cash ISA with them
I opened a cash ISA with them. It was really straightforward to do and interest is added daily. Nice ,easy to use app as well.
Zaproszony
Easy to navigate makes investing…
Easy to navigate makes investing interesting, transferred my investments from HL which was very straightforward and now not paying dealing fee’s
Very Happy
Zaproszony
App is easy to work
App is easy to work
Good interest rate
Daily interest updates
Zaproszony
Very good and informative always stay…
Very good and informative always stay on track with your investments
Zaproszony
Reliable
Reliable, trustworthy app to store your money and to build on your existing wealth if you are financially sensible and smart.
Zaproszony
Great app
Great app. I would recommend to anyone that’s into investing and making their money grow .
Zaproszony
Very easy app to register and use
Very easy app to register and use! Really pleased.
Zaproszony
Clear app
Clear app. Easy to invest. Took a whike for money to get in because i did it from bank rather than in app
Zaproszony
Very smooth and user friendly
Very smooth and user friendly. Have had zero issues having moved from other brokerages. Will keep using.
Zaproszony
Easy to set up and to regular monitor…
Easy to set up and to regular monitor how its performing.
Zaproszony
Competitive rates and quick transfers
Very good on money transfers in and out. They take place immediately unlike some other providers.
Very competitive rate on Cash ISA
Zaproszony
Customer support is quick and…
Customer support is quick and effective. The app is well organised and easy to use. Would reccommend for anyone even complete beginners.
Zaproszony
Easy to set up the Cash ISA
Easy to set up the Cash ISA, funds arrived in account almost immediately. Great to see interest accrual amounts daily.
Zaproszony
Reliable
Reliable, Secure. Using it for past 3 years
Kilka pozytywnych recenzji naszych klientów
Nasze nagrody
Często zadawane pytania
Jaka jest cena akcji Capricor Therapeutics?
Aktualna cena Capricor Therapeutics wynosi 7,59 $.
Jaki jest 52-tygodniowy szczyt Capricor Therapeutics?
52-tygodniowe maksimum dla Capricor Therapeutics wynosi 40,37 $.
Jaki jest 52-tygodniowy poziom minimalny Capricor Therapeutics?
52-tygodniowe minimum dla Capricor Therapeutics wynosi 2,96 $.
Jaki jest tygodniowy wynik Capricor Therapeutics?
W ciągu ostatniego tygodnia cena Capricor Therapeutics zmieniła się o -20,36%.
Jaka jest miesięczna wydajność Capricor Therapeutics?
W ciągu ostatniego miesiąca cena Capricor Therapeutics zmieniła się o 14,14%.
Jaka jest 3-miesięczna wydajność Capricor Therapeutics?
W ciągu ostatnich trzech miesięcy cena Capricor Therapeutics zmieniła się o -4,89%.
Jaka jest 6-miesięczna wydajność Capricor Therapeutics?
W ciągu ostatnich sześciu miesięcy cena Capricor Therapeutics zmieniła się o -71,81%.
Jaka jest roczna wydajność Capricor Therapeutics?
W ciągu ostatniego roku cena Capricor Therapeutics zmieniła się o 31,54%.